Brain metastases in gastroesophageal cancers—an underestimated complication
Autor: | Kathrin Adler, Ute König, Marius Brunner, Volker Ellenrieder, Johanna Reinecke, André Sasse, Kristina Lowes, Ardian Mekolli, Alexander König, Dominik Soll |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
0301 basic medicine Cancer Research medicine.medical_specialty Esophageal Neoplasms Esophageal cancer Gastroenterology Asymptomatic 03 medical and health sciences 0302 clinical medicine Stomach Neoplasms Surgical oncology Internal medicine medicine Humans GEC Esophagus Retrospective Studies Brain Neoplasms business.industry Incidence Cancer Cardia Brain metastases Retrospective cohort study General Medicine Prognosis medicine.disease Cancer registry 030104 developmental biology medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Screening Original Article medicine.symptom Gastric cancer business Complication |
Zdroj: | Gastric Cancer |
ISSN: | 1436-3305 1436-3291 |
DOI: | 10.1007/s10120-021-01219-z |
Popis: | Background Brain metastases represent a severe complication in many gastrointestinal malignancies especially those arising from the upper gastrointestinal tract, including cancer of the esophagus, gastroesophageal junction, and stomach (GEC). However, there is little knowledge about the onset or potential risk factors for brain metastases (BRMs) in upper gastrointestinal cancers resulting in a lack of screening guidelines for BRMs. Methods We analyzed 827 patients from our cancer registry suffering from gastroesophageal cancer (GEC) and treated at the University Medical Center Göttingen between January 2013 and December 2019 for the presence of BRMs. Results From 827 patients with GEC we found 54 patients with BRMs, resulting in an incidence of 6.5%. BRMs are more frequent in male patients (90.74% vs 9.26%, p = 0.0051) and in adenocarcinomas (90.74% vs 9.26%, p = 0.0117). Mean duration for the onset of BRMs from initial cancer diagnoses was 20.9 months in limited disease (curative approach) and 9.3 months in advanced disease (palliative approach) (p = 0.0026). However, early detection of BRMs is a prognostic factor since patients with successful resection of BRMs have a better prognosis compared to those with unresectable BRMs (5.93 vs 2.07 months, p = 0.0091). Conclusion In this single-center retrospective study, brain metastases (BRMs) occur with a high frequency (6.5%) in gastroesophageal cancer (GEC), significantly more often in male patients and adenocarcinomas. Since survival of these patients considerably correlates with successful BRMs resection, our observations propose further prospective trails to validate our hypothesis and ultimately the implementation of routine screening procedures to detect asymptomatic brain metastases. |
Databáze: | OpenAIRE |
Externí odkaz: |